{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:17:15Z","timestamp":1778217435737,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1136\/ard.2003.014050","type":"journal-article","created":{"date-parts":[[2004,6,11]],"date-time":"2004-06-11T17:48:16Z","timestamp":1086976096000},"page":"797-803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"title":["Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial"],"prefix":"10.1016","volume":"63","author":[{"given":"H A","family":"Capell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Madhok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J A","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Larkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E A","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Hampson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F W","family":"Poon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2003.014050_bib1","unstructured":"Scottish Intercollegiate Guidelines Network. Management of early rheumatoid arthritis. Edinburgh: SIGN Executive, Royal College of Physicians of Edinburgh, No 48, December 2000."},{"key":"10.1136\/ard.2003.014050_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0025-6196(24)00526-3","article-title":"The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocortisone: Compound E) and of pituitary adrenocorticotrophic hormone on rheumatoid arthritis. Preliminary report","volume":"24","author":"Hench","year":"1949","journal-title":"Prof Staff Meet Mayo Clin"},{"key":"10.1136\/ard.2003.014050_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/ard.18.3.173","article-title":"A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis","volume":"18","year":"1959","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2003.014050_bib4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/rheumatology\/29.4.274","article-title":"Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: a randomised clinical trial","volume":"29","author":"Corkhill M , Kirkham","year":"1990","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2003.014050_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/rheumatology\/34.4.347","article-title":"Oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold. A randomized double-blind placebo-controlled trial","volume":"34","author":"van Gestel","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2003.014050_bib6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/ard.58.11.713","article-title":"A randomised trial of differentiated prednisolone treatment in active rheumatoid arthritis. Clinical benefits and skeletal side-effects","volume":"58","author":"Hansen M , Podenphant","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2003.014050_bib7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM199507203330302","article-title":"The effect of glucocorticoids on joint destruction in rheumatoid arthritis","volume":"333","author":"Kirwan","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2003.014050_bib8","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/rheumatology\/37.9.930","article-title":"Arthritis and Rheumatism Council low dose glucocorticoid study group","volume":"37","author":"Hickling P , Jacoby","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2003.014050_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-136-1-200201010-00006","article-title":"Low-dose prednisolone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side-effects: a randomised, double-blind, placebo-controlled clinical trial","volume":"136","author":"Van Everdingen","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2003.014050_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(97)01300-7","article-title":"Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis","volume":"350","author":"Boers M , Verhoeven","year":"1997","journal-title":"Lancet"},{"key":"10.1136\/ard.2003.014050_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/rheumatology\/38.2.95","article-title":"The case for corticosteroids in the treatment of early rheumatoid arthritis","volume":"38","author":"Boers","year":"1999","journal-title":"Rheumatology"},{"key":"10.1136\/ard.2003.014050_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/rheumatology\/38.2.97","article-title":"Corticosteroids in rheumatoid arthritis \u2013 the case against","volume":"38","author":"Morrison E , Capell","year":"1999","journal-title":"Rheumatology"},{"key":"10.1136\/ard.2003.014050_bib13","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/rheumatology\/40.12.1375","article-title":"Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis","volume":"40","author":"de Nijs","year":"2001","journal-title":"Rheumatology"},{"key":"10.1136\/ard.2003.014050_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.61.1.32","article-title":"Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice","volume":"61","author":"Gudbjornsson B , Juliusson","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2003.014050_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0002-9343(97)90006-1","article-title":"Low-dose corticosteroid therapy in rheumatoid arthritis: balancing the evidence","volume":"103","author":"Saag","year":"1997","journal-title":"Am J Med"},{"key":"10.1136\/ard.2003.014050_bib16","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/1529-0131(200110)45:5<468::AID-ART367>3.0.CO;2-A","article-title":"Resolved: low-dose glucocorticoids are neither safe nor effective for the long-term treatment of rheumatoid arthritis","volume":"45","author":"Saag","year":"2001","journal-title":"Arthritis Care Res"},{"key":"10.1136\/ard.2003.014050_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.1780370408","article-title":"The mortality of rheumatoid arthritis","volume":"37","author":"Wolfe F , Mitchell","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.014050_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987: Revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.014050_bib19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/cpt1974155443","article-title":"Minimization: a new method of assigning patients to treatment and control groups","volume":"15","author":"Taves","year":"1974","journal-title":"Clin Pharmacol Ther"},{"key":"10.1136\/ard.2003.014050_bib20","first-page":"362","article-title":"Minimisation: the platinum standard for trials? Randomisation doesn\u2019t guarantee similarity of groups; minimisation does [Editorial]","volume":"317","author":"Treasure T , MacRae","year":"1998","journal-title":"BMJ"},{"key":"10.1136\/ard.2003.014050_bib21","article-title":"Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment","year":"1997","journal-title":"Statement on vitamin B6 (pyridoxine) toxicity"},{"key":"10.1136\/ard.2003.014050_bib22","author":"Carstairs","year":"1991","journal-title":"Deprivation and health in Scotland"},{"key":"10.1136\/ard.2003.014050_bib23","first-page":"393","article-title":"Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis","volume":"147","author":"Ritchie","year":"1968","journal-title":"Q J Med"},{"key":"10.1136\/ard.2003.014050_bib24","first-page":"789","article-title":"The dimensions of health outcomes: the Health Assessment Questionnaire, disability and pain scales","volume":"9","author":"Fries","year":"1982","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2003.014050_bib25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/rheumatology\/25.2.206","article-title":"Standford health assessment questionnaire modified to assess disability in British patients with rheumatoid arthritis","volume":"25","author":"Kirwan","year":"1986","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2003.014050_bib26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0950-3579(96)80043-4","article-title":"Plain x-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability","volume":"10","author":"van der Heijde","year":"1996","journal-title":"Baillieres Clin Rheumatol"},{"key":"10.1136\/ard.2003.014050_bib27","unstructured":"Bruynesteyn K, van der Heijde D, Boers M, Saudan A, Peloso P, Paulus H, et al. Reading films with or without known sequence: does it influence the accuracy to detect clinically important changes in the individual [abstract]. San Francisco: ACR 65th Annual Scientific Meeting, November, 2001."},{"key":"10.1136\/ard.2003.014050_bib28","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/ard.60.10.924","article-title":"Predictors of radiographic joint damage in patients with early rheumatoid arthritis","volume":"60","author":"Jansen","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2003.014050_bib29","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/art.10167","article-title":"Rheumatoid factor is the major predictor if increasing severity of radiographic erosions in rheumatoid arthritis","volume":"46","author":"Bukhari M , Lunt","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.014050_bib30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/028418517701800415","article-title":"Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films","volume":"18","author":"Larsen A , Dale","year":"1977","journal-title":"Acta Radiol Diagn"},{"key":"10.1136\/ard.2003.014050_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0140-6736(98)09403-3","article-title":"Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial","volume":"353","author":"Smolen","year":"1999","journal-title":"Lancet"},{"key":"10.1136\/ard.2003.014050_bib32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/ard.58.2.114","article-title":"Genotyping for disease associated HLA DR \u03b21 alleles and the need for early joint surgery in rheumatoid arthritis: a quantitative evaluation","volume":"58","author":"Crilly A , Maiden","year":"1999","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724185251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724185251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2003.014050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T05:27:55Z","timestamp":1737350875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724185251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0003496724185251"],"URL":"https:\/\/doi.org\/10.1136\/ard.2003.014050","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2003.014050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Copyright 2004 by Annals of the Rheumatic Diseases. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}